Extracorporeal Membrane Oxygenation Machine Market - 2022-2030
The Extracorporeal Membrane Oxygenation Machine Market was valued at USD 553 million in 2022 and is anticipated to reach USD 708 million by 2030, at a CAGR of 0.051 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Extracorporeal Membrane Oxygenation Machine Market.
This report delivers a comprehensive overview of the Extracorporeal Membrane Oxygenation Machine Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation Machine Market. The Extracorporeal Membrane Oxygenation Machine Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
Extracorporeal Membrane Oxygenation Machine Market Scope:
By Modality Type
This report delivers a comprehensive overview of the Extracorporeal Membrane Oxygenation Machine Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation Machine Market. The Extracorporeal Membrane Oxygenation Machine Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Extracorporeal Membrane Oxygenation Machine Market.
This report delivers a comprehensive overview of the Extracorporeal Membrane Oxygenation Machine Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation Machine Market. The Extracorporeal Membrane Oxygenation Machine Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
Extracorporeal Membrane Oxygenation Machine Market Scope:
By Modality Type
- Veno-arterial (VA)
- Veno-venous (VV)
- Arterio-venous (AV)
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
- Medtronic plc.
- MAQUET Holding B. V. & Co. KG
- LivaNova PLC
- XENIOS AG
- Terumo Corporation
- MicroPort Scientific Corporation
- NIPRO Corporation
- OriGen Biomedical Inc
- ALung Technologies Inc
- EUROSETS S.r.l.LIST NOT EXHAUSTIVE
This report delivers a comprehensive overview of the Extracorporeal Membrane Oxygenation Machine Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation Machine Market. The Extracorporeal Membrane Oxygenation Machine Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2022–2030.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing prevalence rates of lung cancer and increasing geriatric population
4.1.2. Restraints:
4.1.2.1. High Cost and adverse effects associated with some extracorporeal membrane oxygenation machine
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
5.6. Product innovations
6. BY MODALITY TYPE
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type Segment
6.1.2. Market Attractiveness Index, By Modality Type Segment
6.2. Veno-arterial (VA)
6.2.1.1. Introduction
6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.3. Veno-venous (VV)
6.4. Arterio-venous (AV)
7. BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
7.1.2. Market Attractiveness Index, By Application Segment
7.2. Respiratory
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Cardiac
7.4. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
8. BY COMPONENT
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component Segment
8.1.2. Market Attractiveness Index, By Component Segment
8.2. Pumps
8.2.1.1. Introduction
8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Oxygenators
8.4. Controllers
8.5. Cannula
8.6. Accessories
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
10. COMPETITIVE LANDSCAPE
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Products Benchmarking
10.4. List of Key Companies to Watch
11. COMPANY PROFILES
11.1. Medtronic plc.
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. MAQUET Holding B. V. & Co. KG
11.3. LivaNova PLC
11.4. XENIOS AG
11.5. Terumo Corporation
11.6. MicroPort Scientific Corporation
11.7. NIPRO Corporation
11.8. OriGen Biomedical Inc
11.9. ALung Technologies Inc
11.10. EUROSETS S.r.l.LIST NOT EXHAUSTIVE
12. DATAM INTELLIGENCE
12.1. Appendix
12.2. About Us and Component
12.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing prevalence rates of lung cancer and increasing geriatric population
4.1.2. Restraints:
4.1.2.1. High Cost and adverse effects associated with some extracorporeal membrane oxygenation machine
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Regulatory Analysis
5.3. Supply Chain Analysis
5.4. Pricing Analysis
5.5. Unmet Needs
5.6. Product innovations
6. BY MODALITY TYPE
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type Segment
6.1.2. Market Attractiveness Index, By Modality Type Segment
6.2. Veno-arterial (VA)
6.2.1.1. Introduction
6.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.3. Veno-venous (VV)
6.4. Arterio-venous (AV)
7. BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
7.1.2. Market Attractiveness Index, By Application Segment
7.2. Respiratory
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Cardiac
7.4. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
8. BY COMPONENT
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component Segment
8.1.2. Market Attractiveness Index, By Component Segment
8.2. Pumps
8.2.1.1. Introduction
8.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Oxygenators
8.4. Controllers
8.5. Cannula
8.6. Accessories
9. BY REGION
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. U.K.
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Modality Type
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
10. COMPETITIVE LANDSCAPE
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Products Benchmarking
10.4. List of Key Companies to Watch
11. COMPANY PROFILES
11.1. Medtronic plc.
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. MAQUET Holding B. V. & Co. KG
11.3. LivaNova PLC
11.4. XENIOS AG
11.5. Terumo Corporation
11.6. MicroPort Scientific Corporation
11.7. NIPRO Corporation
11.8. OriGen Biomedical Inc
11.9. ALung Technologies Inc
11.10. EUROSETS S.r.l.LIST NOT EXHAUSTIVE
12. DATAM INTELLIGENCE
12.1. Appendix
12.2. About Us and Component
12.3. Contact Us
